Hope in the fight against HIV: prophylactic vaccine candidate shows encouraging results
PressThis innovative vaccine candidate called CD40.HIVRI.Env, demonstrated its safety and ability to induce a rapid and durable immune response in the phase I ANRS VRI06 clinical trial . image : pexels-ron-lach-9893851 This result is the outcome of a collaborative research project between the Vaccine Research Institute (VRI), https://vaccine-research-institute.fr/fr of Inserm, Université Paris-Est Créteil, […]